Ishibashi Laboratory

About the Lab
-
Lab Focus Areas
Congenital Heart Disease and Neuroprotection
Brain Injury, Recovery and Protection
White matter development and function
-
Contact
Nobuyuki Ishibashi, M.D. Director, Cardiac Surgery Research Laboratory [email protected]
Featured Publications
-
Impact of mesenchymal stromal cell delivery through cardiopulmonary bypass on postnatal neurogenesis
Maeda T, Sarkislali K, Leonetti C, Kapani N, Dhari Z, Al haj I, Ulrey R, Hanley PJ, Jonas RA, Ishibashi N PMID: 31563487 Ann Thorac Surg 109:1274-1281 April (2020) -
Treatment with tetrahydrobiopterin improves white matter maturation in a mouse model for prenatal hypoxia in congenital heart disease
Romanowicz J, Leonetti C, Dhari Z, Korotcova L, Ramachandra SD, Saric N, Morton PD, Bansal S, Cheema A, Gallo V, Jonas RA, Ishibashi N PMID: 31331224 J Am Heart Assoc 8(15):e012711 August (2019) -
Cortical dysmaturation in congenital heart disease
Leonetti C, Back SA, Gallo V, Ishibashi N PMID: 30616953 Trends Neurosci January (2019) -
Abnormal neurogenesis and cortical growth in congenital heart disease
Morton PD, Korotcova L, Lewis BK, Bhuvanendran S, Ramachandra SD, Zurakowski D, Zhang J, Mori S, Frank JA, Jonas, RA, Gallo V, Ishibashi N PMID: 28123074 Sci Transl Med 25;9 January (2017) -
Microstructural alterations and oligodendrocyte dysmaturation in white matter after cardiopulmonary bypass in a juvenile porcine model
Stinnett GR, Lin S, Korotcov AV, Korotcova L, Morton PD, Ramachandra SD, Pham A, Kumar S, Agematsu K, Zurakowski D, Wang PC, Jonas RA, Ishibashi N PMID: 28862938 J Am Heart Assoc 6(8) August (2017)

Cell therapy research for neuroprotection in congenital heart disease receives another $3.3 million from NIH
August 18, 2023Cell therapy research for neuroprotection in congenital heart disease receives another $3.3 million from NIH.
Read More